If the U.S. loses its leadership role in the $2 trillion global biotech industry, will it be a victory by China’s government or a self-inflicted American defeat? Vance Ginn is adamant that it will be the latter, which is why he’s urging the Trump administration to abandon its restrictive tariff and regulatory approach and embrace […]
